×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Jeevan Scientific Technology L | NA | NA | NA | NA | 63.4 | 1,268 |
| GODAVARI DRUGS LTD. | NA | NA | NA | NA | 62.4 | 16.5 |
| TRANSCHEM LTD. | NA | NA | NA | NA | 58.2 | 12.8 |
Jeevan Scientific Technology Limited, with Security Code 538837, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.0 | 7.9 | 10.4 | 8.1 | 10.1 | 9.9 | 12.5 | 10.3 | 11.9 | 8.9 |
| Expenses | 8.5 | 9.0 | 8.3 | 7.4 | 9.0 | 9.4 | 9.1 | 8.4 | 9.8 | 9.8 |
| Operating Profit | 1.5 | -1.0 | 2.0 | 0.7 | 1.1 | 0.6 | 3.4 | 1.9 | 2.0 | -0.9 |
| OPM % | 14.69% | -13.12% | 19.7% | 8.33% | 10.78% | 5.54% | 27.09% | 18.88% | 17.18% | -9.99% |
| Other Income | 0.3 | 0.3 | 0.3 | 0.3 | -0.1 | 0.3 | 0.1 | 0.2 | 0.2 | 0.1 |
| Interest | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 |
| Depreciation | 1.3 | 1.4 | 1.4 | 1.4 | 1.3 | 1.4 | 1.3 | 1.3 | 1.2 | 1.5 |
| Profit before tax | 0.2 | -2.4 | 0.7 | -0.7 | -0.5 | -0.8 | 2.1 | 0.6 | 0.8 | -2.6 |
| Tax % | -71.9% | -6.2% | -20% | -27.6% | -21.4% | -3.5% | -22.7% | -74.5% | -57.9% | 0% |
| Net Profit | 0.1 | -2.3 | 0.6 | -0.5 | -0.4 | -0.7 | 1.6 | 0.2 | 0.3 | -1.3 |
| EPS in Rs | 0.04 | -1.47 | 0.36 | -0.32 | -0.25 | -0.48 | 1.03 | 0.1 | 0.2 | 0 |
| Metrics | Mar 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.9 | 7.9 | 10.4 | 8.1 | 10.1 | 11.1 | 12.9 | 11.4 | 12.5 | 10.1 |
| Expenses | 14.0 | 9.0 | 8.4 | 7.5 | 9.1 | 10.1 | 9.7 | 8.9 | 10.4 | 10.4 |
| Operating Profit | -2.1 | -1.0 | 2.0 | 0.6 | 1.0 | 1.0 | 3.2 | 2.5 | 2.1 | -0.3 |
| OPM % | -17.75% | -13.17% | 19.52% | 7.45% | 10% | 8.82% | 25.04% | 21.89% | 16.57% | -3.23% |
| Other Income | 5.1 | 0.3 | 0.3 | 0.3 | -0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 |
| Interest | 0.2 | 0.3 | 0.2 | 0.3 | 0.1 | 0.3 | 0.3 | 0.5 | 0.4 | 0.5 |
| Depreciation | 0.7 | 1.4 | 1.5 | 1.4 | 1.4 | 1.6 | 1.5 | 1.5 | 1.5 | 1.8 |
| Profit before tax | 2.1 | -2.5 | 0.6 | -0.8 | -0.6 | -0.8 | 1.5 | 0.7 | 0.4 | -2.5 |
| Tax % | -70.6% | -6.2% | -19.3% | -26% | -24.1% | -3.6% | -31.3% | -65.2% | -88.3% | 0% |
| Net Profit | 0.6 | -2.3 | 0.5 | -0.6 | -0.5 | -0.7 | 1.0 | 0.3 | 0.0 | -1.3 |
| EPS in Rs | 0.52 | -1.51 | 0.32 | -0.39 | -0.31 | -0.47 | 0.66 | 0.16 | 0.03 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 9% |
| 3 Years: | -2% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 152% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 15% |
| 3 Years: | -21% |
| 1 Year: | -14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | -5% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 121% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 16% |
| 3 Years: | -20% |
| 1 Year: | -13% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|